Ads
related to: pfizer
Search results
Pfizer offers up to $250 million to settle Zantac cancer lawsuits, FT reports
Reuters via Yahoo Finance· 6 days agoThe drugmaker was set to pay between $200 million and $250 million in the settlement, the newspaper...
GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims
Benzinga· 3 hours agoRelated: Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks Associated With...
3 Reliable Dividend Stocks With Yields Above 5% You Can Buy With Less Than $100 Right Now
Motley Fool via Yahoo Finance· 2 days agoIf you have an extra $100 to invest, you could set yourself up with dividends from Realty Income...
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
Reuters via AOL· 4 days agoThe company has been locked in a legal battle with Pfizer-BioNTech over their COVID shot Comirnaty...
Pfizer wins cancer drug patent case against AstraZeneca
Pharmaceutical Technology via Yahoo Finance· 2 days agoThe US District Court for the District of Delaware has ordered AstraZeneca to pay $107.5m to Pfizer...
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 4 days agoPfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might...
Pfizer Settles Zantac Lawsuits, Agrees To $250M Settlement To Reduce Liability: Report - Pfizer...
Benzinga· 6 days agoIn a bid to settle thousands of lawsuits over its discontinued heartburn drug Zantac, Pfizer Inc....
AstraZeneca sets sights on $80B in revenue by 2030
BioPharma Dive via Yahoo Finance· 10 hours agoA decade ago, as British drugmaker AstraZeneca fought off a hostile takeover bid by Pfizer, CEO Pascal Soriot made a big promise: The company, he said,...
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial
Reuters via AOL· 4 days agoAstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after...
Pfizer Inc.’s latest rating changes from various analysts – Knox Daily
Knox Daily· 2 days agoPfizer Inc.’s recently made public that its Director Gottlieb Scott acquired Company’s shares for reported $79401.0 on Dec 15 ’23. In the deal valued at $26.47 per share,3,000 ...
